MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
236 M |
Market Cap[1] |
$ 21.2 M |
EBITDA (LTM) |
$ -1.62 B |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-6.24 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Brainsway Ltd.
BWAY
|
$ 19.33 | 0.21 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
$ 20.97 | -1.38 % | $ 226 M | Nasdaq Global Market |  China |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 0.23 | -4.4 % | $ 6.75 M | Nasdaq Capital Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 39.53 | -1.4 % | $ 1.1 B | Nasdaq Global Market,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.52 | - | $ 1.93 M | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.17 | 1.29 % | $ 289 M | Nasdaq Capital Market | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DexCom
DXCM
|
$ 67.51 | 0.13 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 230.0 | -0.45 % | $ 168 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.56 | 0.02 % | $ 18.8 B | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 26.78 | -0.85 % | $ 810 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.47 | -1.32 % | $ 1.05 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 101.9 | -0.7 % | $ 4.02 B | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.21 | -6.25 % | $ 102 K | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 226.52 | 0.26 % | $ 41.1 B | NYSE,SPB | USA |
 |
Guardant Health
GH
|
$ 103.35 | 0.94 % | $ 12.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 6.44 | -1.68 % | $ 583 M | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 135.12 | -0.15 % | $ 21.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 203.88 | - | $ 10.5 B | NYSE,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.94 | -3.14 % | $ 2.65 M | Nasdaq Global Select Market | USA |
 |
Neogen Corporation
NEOG
|
$ 7.12 | -0.35 % | $ 1.54 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.74 | 0.46 % | $ 460 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 176.16 | 0.15 % | $ 19.6 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 6.76 | -0.88 % | $ 877 M | Nasdaq Global Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
$ 254.32 | 0.02 % | $ 21.3 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 182.75 | -0.51 % | $ 15.1 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 688.22 | 0.01 % | $ 56.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.77 | -5.85 % | $ 449 M | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.73 | 0.07 % | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 419.64 | 0.11 % | $ 30.1 B | NYSE,SPB |  Schweiz |
 |
Agilent Technologies
A
|
$ 138.31 | 0.03 % | $ 42 B | NYSE,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.7 | 1.9 % | $ 6.2 M | Nasdaq Capital Market | USA |
 |
Bioventus
BVS
|
$ 7.4 | 0.27 % | $ 464 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 12.33 | 0.2 % | $ 1.56 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.